BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3860290)

  • 1. Relationships between morphology, dissemination, migration, and prostaglandin E2 secretion by cloned variants of Lewis lung carcinoma.
    Young MR; Newby M; Meunier J
    Cancer Res; 1985 Aug; 45(8):3918-23. PubMed ID: 3860290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
    Young MR; Young ME; Wepsic HT
    Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
    Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
    Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages.
    Young MR; Newby M
    Cancer Res; 1986 Jan; 46(1):160-4. PubMed ID: 3455665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination.
    Mahan M; Meunier J; Newby M; Young MR
    J Natl Cancer Inst; 1985 Jan; 74(1):191-5. PubMed ID: 3855478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of increased tumor cell responsiveness to prostaglandin E2 with more aggressive tumor behavior.
    Young MR; Okada F; Tada M; Hosokawa M; Kobayashi H
    Invasion Metastasis; 1991; 11(1):48-57. PubMed ID: 2061004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo.
    Young MR; Knies S
    J Natl Cancer Inst; 1984 Apr; 72(4):919-22. PubMed ID: 6584667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic heterogeneity of cells from Lewis lung carcinoma.
    van Lamsweerde AL; Henry N; Vaes G
    Cancer Res; 1983 Nov; 43(11):5314-20. PubMed ID: 6616467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
    Young MR; Hoover CS
    J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of protein kinase A increases the in vitro invasion, migration, and adherence to reconstituted basement membrane by Lewis lung carcinoma tumor cells.
    Young MR; Young ME; Lozano Y; Bagash JM
    Invasion Metastasis; 1992; 12(5-6):253-63. PubMed ID: 1298738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
    Young MR; Newby M
    J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesiveness and morphology of Lewis lung carcinoma variants influence their sensitivity to natural killer cytolysis and their metastatic capacity.
    Young MR; Duffie GP; Newby M
    Invasion Metastasis; 1987; 7(2):96-108. PubMed ID: 3583624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
    Stackpole CW
    Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities.
    Ho MY; Leu SJ; Sun GH; Tao MH; Tang SJ; Sun KH
    J Immunol; 2009 Nov; 183(10):6217-26. PubMed ID: 19841177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells.
    Nakanishi H; Oguri K; Takenaga K; Hosoda S; Okayama M
    Lab Invest; 1994 Mar; 70(3):324-32. PubMed ID: 7511714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
    Olsson L; Kiger N; Kronstrom H
    Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of protein kinase A activation and prostaglandin E2-stimulated migration of Lewis lung carcinoma clones.
    Young MR; Young ME; Lozano Y; Coogan M; Bagash JM
    Int J Cancer; 1991 Aug; 49(1):150-5. PubMed ID: 1651907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor heterogeneity and stability of the metastatic phenotype of mouse KHT sarcoma cells.
    Chambers AF; Hill RP; Ling V
    Cancer Res; 1981 Apr; 41(4):1368-72. PubMed ID: 7214323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effects of prostaglandin E1 and indomethacin on the growth and metastasis of transplanted Lewis lung carcinoma in C57BL mice.
    Tang DG; Tian HS
    Chin Med J (Engl); 1990 Mar; 103(3):208-15. PubMed ID: 2164465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamics of binding of various prostanoids in mouse serum with spontaneous metastatic Lewis lung carcinoma; effect of exogenous prostaglandins on dissemination of the tumor].
    Mikhaĭlevskaia LL; Vavilova VG; Selezneva LA; Kinzirskiĭ AS
    Biull Eksp Biol Med; 1994 Mar; 117(3):296-8. PubMed ID: 8204857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.